SEC Form 4 research
| Issuer | 4D Molecular Therapeutics, Inc. |
|---|---|
| Tickers | FDMT, FMDT |
| Reporting owners | 44 |
| Officers and directors | 9 |
| Last public filing | 2026-10-07 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-05 | Kirn David | S | 272 | $13.61 | Not reported |
| 2026-10-07 | 2026-10-05 | Kirn David | S | 58,061 | $12.92 | Not reported |
| 2026-09-22 | 2026-09-16 | Bizily Scott | S | 1,635 | $13.65 | Not reported |
| 2026-09-16 | 2026-09-14 | Kirn David | S | 58,333 | $13.9 | Not reported |
| 2026-09-03 | 2026-09-01 | Bizily Scott | S | 584 | $14 | Not reported |
| 2026-08-21 | 2026-08-19 | Kirn David | S | 25,927 | $16.42 | Not reported |
| 2026-08-21 | 2026-08-19 | Kirn David | S | 43,149 | $15.36 | Not reported |
| 2026-08-17 | 2026-08-17 | Bizily Scott | S | 1,635 | $12.2 | Not reported |
| 2026-08-17 | 2026-08-13 | Bizily Scott | S | 1,635 | $12 | Not reported |
| 2026-08-05 | 2026-08-04 | Kirn David | S | 26,842 | $10.23 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.